Advertisement

PharmacoEconomics & Outcomes News

, Volume 781, Issue 1, pp 27–27 | Cite as

Pembrolizumab worth extra cost in advanced melanoma

Clinical study
  • 16 Downloads

Reference

  1. Miguel LS, et al. Cost-Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal. Value in Health : 20 Jun 2017. Available from: URL: https://doi.org/10.1016/j.jval.2017.05.009

Copyright information

© Springer International Publishing AG  2017

Personalised recommendations